Verition Fund Management
ELEV

Verition Fund Management’s Elevation Oncology ELEV Stock Holding History

Verition Fund Management’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,503
Closed -$28.1K – 3817
2025
Q2 		$28.1K Sell
76,503
-361,692
-83% -$121K ﹤0.01% 3556
2025
Q1 		$114K Buy
+438,195
New +$250K ﹤0.01% 3142

Other funds holding ELEV

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Verition Fund Management's ELEV Position: Q3 2025 in Review

Verition Fund Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 76,503 shares — an estimated $28.1K sold.

Verition Fund Management first reported a position in ELEV in Q1 2025 and held it in 2 quarters. The position peaked at $114K in Q1 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

  • Verition Fund Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 76,503 Elevation Oncology shares in Q3 2025, an estimated $28.1K.
  • Verition Fund Management first reported a position in Elevation Oncology in Q1 2025 and held it in 2 quarters.
  • Verition Fund Management's Elevation Oncology position peaked at $114K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.